Comment on Frey et al A Real-World Pharmacovigilance Analysis of Lorlatinib-Associated Metabolic Effects Using the FDA Adverse Events Reporting System (FAERS) Database From 2013 to 2024

Endocrine Practice 2026

View at publisher

Authors: Parth Aphale, Himanshu Shekhar, Shashank Dokania

DOI: 10.1016/j.eprac.2025.08.011

Cited by: 0

References: 5

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Lung Cancer Treatments and Mutations Pharmacology and Obesity Treatment

References 5